Dearborn Partners Portfolio holdings
Dearborn Partners builds portfolios of companies it expects to keep raising their dividends, an approach it calls its Rising Dividend strategy. Three Chicago investment managers who wanted to offer more personal service joined together to form the firm in 1997. Carol Lippman, who began formulating the Rising Dividend approach in 1993 at another firm, joined in 2011 and manages the strategy, with Michael Andelman as co-portfolio manager. Dearborn also advises the Dearborn Partners Rising Dividend Fund, a mutual fund, and serves financial advisors, high net worth families and institutional investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$1.4M |
| 2 |
CVS Health
CVS
|
+$1.2M |
| 3 |
United Parcel Service
UPS
|
+$1.13M |
| 4 |
Apple
AAPL
|
+$1.05M |
| 5 |
XLNX
Xilinx Inc
XLNX
|
+$1.05M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Morningstar Mega Cap Growth ETF
MGK
|
+$823K |
| 2 |
State Street SPDR Portfolio Short Term Corporate Bond Index ETF
SPSB
|
+$671K |
| 3 |
Vanguard Short-Term Corporate Bond ETF
VCSH
|
+$569K |
| 4 |
iShares Currency Hedged MSCI EAFE ETF
HEFA
|
+$372K |
| 5 |
Zebra Technologies
ZBRA
|
+$236K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 16.35% |
| 2 | Technology | 15.73% |
| 3 | Industrials | 13.42% |
| 4 | Consumer Staples | 11.59% |
| 5 | Consumer Discretionary | 6.95% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
1
Johnson & Johnson
JNJ
$676B
| $35.1M | 3.04% |
289,247
+3,896
| +1% | +$443K |
2013 Q2
12 quarters
|
|
2
General Mills
GIS
$18.5B
| $32.4M | 2.81% |
453,595
+8,921
| +2% | +$568K |
2013 Q2
12 quarters
|
|
3
Becton Dickinson
BDX
$57.9B
| $30.1M | 2.61% |
182,036
+6,080
| +3% | +$972K |
2013 Q2
12 quarters
|
|
4
Novartis
NVS
$308B
| $28.3M | 2.45% |
382,212
+11,636
| +3% | +$804K |
2013 Q2
12 quarters
|
|
5
Illinois Tool Works
ITW
$81.9B
| $28.2M | 2.45% |
271,218
+6,520
| +2% | +$683K |
2013 Q2
12 quarters
|
|
6
3M
MMM
$97.7B
| $27.2M | 2.36% |
185,811
+3,572
| +2% | +$504K |
2013 Q2
12 quarters
|
|
7
McDonald's
MCD
$199B
| $26.8M | 2.32% |
222,558
+4,557
| +2% | +$571K |
2013 Q2
12 quarters
|
|
8
Chevron
CVX
$412B
| $26.3M | 2.28% |
250,850
+5,126
| +2% | +$516K |
2013 Q2
12 quarters
|
|
9
AT&T
T
$148B
| $24.9M | 2.16% |
762,308
+19,990
| +3% | +$595K |
2013 Q2
12 quarters
|
|
10
Automatic Data Processing
ADP
$121B
| $24.8M | 2.15% |
269,682
+6,000
| +2% | +$530K |
2013 Q2
12 quarters
|
|
11
DELISTED
Valspar
VAL
| $24.4M | 2.11% |
225,474
+5,543
| +3% | +$595K |
2013 Q2
12 quarters
|
|
12
Realty Income
O
$56.6B
| $23.3M | 2.02% |
346,551
+9,056
| +3% | +$550K |
2013 Q2
12 quarters
|
|
13
J.M. Smucker
SJM
$14.3B
| $22.7M | 1.97% |
149,226
+4,826
| +3% | +$642K |
2013 Q2
12 quarters
|
|
14
Kimberly-Clark
KMB
$68B
| $21.2M | 1.84% |
154,480
+5,115
| +3% | +$669K |
2013 Q2
12 quarters
|
|
15
Coca-Cola
KO
$417B
| $20.9M | 1.81% |
460,963
+14,260
| +3% | +$644K |
2013 Q2
12 quarters
|
|
16
Qualcomm
QCOM
$186B
| $20.7M | 1.8% |
387,261
+18,285
| +5% | +$964K |
2013 Q2
12 quarters
|
|
17
Republic Services
RSG
$75.4B
| $20.3M | 1.76% |
394,789
+11,786
| +3% | +$566K |
2013 Q2
12 quarters
|
|
|
18
Apple
AAPL
$5.06T
| $20M | 1.74% |
838,272
+42,288
| +5% | +$1.05M |
2013 Q2
12 quarters
|
|
19
Xcel Energy
XEL
$51.4B
| $19.6M | 1.7% |
438,203
+10,536
| +2% | +$436K |
2013 Q2
12 quarters
|
|
20
ExxonMobil
XOM
$671B
| $19.6M | 1.7% |
209,169
+5,046
| +2% | +$446K |
2013 Q2
12 quarters
|
|
|
21
United Parcel Service
UPS
$94.6B
| $18.7M | 1.62% |
173,179
+10,904
| +7% | +$1.13M |
2013 Q2
12 quarters
|
|
22
WEC Energy
WEC
$38.5B
| $18.5M | 1.6% |
283,050
+1,768
| +0.6% | +$106K |
2014 Q1
9 quarters
|
|
23
Steris
STE
$25B
| $18.4M | 1.6% |
267,387
+5,433
| +2% | +$381K |
2013 Q2
12 quarters
|
|
24
VF Corp
VFC
$8.16B
| $18.3M | 1.59% |
316,225
+15,100
| +5% | +$893K |
2013 Q2
12 quarters
|
|
25
IBM
IBM
$231B
| $17.5M | 1.52% |
120,546
+3,366
| +3% | +$482K |
2013 Q2
12 quarters
|
|
Similar funds
Dearborn Partners's Q2 2016 Portfolio in Review
As of Q2 2016, Dearborn Partners held 190 positions worth $1.15B, up 7.2% from $1.08B the previous quarter. Its ten largest holdings account for 25% of the portfolio.
Dearborn Partners's Q2 2016 filing shows 8 new, 98 increased, 51 reduced and 6 closed positions. Its largest new stake was Vanguard FTSE Emerging Markets ETF: 15,191 shares worth $535K. The largest sale was Vanguard Morningstar Mega Cap Growth ETF, an estimated $823K.
By sector, the portfolio is most concentrated in Healthcare at 16% of assets, up from 16% a quarter earlier, followed by Technology and Industrials.
- Dearborn Partners's largest Q2 2016 buy was Vanguard FTSE Emerging Markets ETF: 15,191 shares worth $535K.
- Dearborn Partners added most to Gilead Sciences in Q2 2016, an estimated $1.4M increase.
- Dearborn Partners's biggest Q2 2016 reduction was Vanguard Morningstar Mega Cap Growth ETF, cutting an estimated $823K.
- Dearborn Partners fully exited iShares Currency Hedged MSCI EAFE ETF in Q2 2016, selling an estimated $372K.
- Dearborn Partners's ten largest holdings make up 25% of its $1.15B portfolio in Q2 2016.
- Dearborn Partners opened 8 new positions and closed 6 in Q2 2016.
- Dearborn Partners's portfolio value rose 7.2% quarter-over-quarter to $1.15B.
Based on Dearborn Partners's 13F filing for Q2 2016, filed 18 Jul 2016.